News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
JOBES ELIZABETH VARKI
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/18/2023 |
4
| JOBES ELIZABETH VARKI (Director) has filed a Form 4 on Blue Foundry Bancorp|
Txns:
| Bought 2,204 shares
@ $8.8996, valued at
$19.6k
Bought 43 shares
@ $8.8999, valued at
$382.7 |
|
| 01/11/2023 |
3
| JOBES ELIZABETH VARKI (Director) has filed a Form 3 on Blue Foundry Bancorp |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/30/2015 |
4
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 13,767 shares
@ $36.53, valued at
$502.9k
Disposed of 20,000 options to buy
@ $17.68, valued at
$353.6k
Disposed of 11,250 options to buy
@ $18.3, valued at
$205.9k
Disposed of 13,700 options to buy
@ $28.3, valued at
$387.7k
|
|
| 11/26/2014 |
4
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Sold 4,052 shares
@ $34.0483, valued at
$138k
Sold 23,750 shares
@ $34.0341, valued at
$808.3k
Exercised 20,000 options to buy
@ $17.68, valued at
$353.6k
Exercised 3,750 options to buy
@ $18.3, valued at
$68.6k
|
|
| 05/08/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/12/2014 |
4/A
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 6,000 shares
@ $0
Granted 5,500 shares
@ $0 |
|
| 02/20/2014 |
4
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 4,875 shares
@ $0
Paid exercise price by delivering 535 shares
@ $28.3, valued at
$15.1k
Granted 5,500 shares
@ $0
Granted 13,700 options to buy
@ $28.3, valued at
$387.7k
Granted 9,200 options to buy
@ $0 |
|
| 02/11/2014 |
4
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 716 shares
@ $23.68, valued at
$17k
|
|
| 02/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/25/2012 |
3
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 3 on AUXILIUM PHARMACEUTICALS INC |
|
|